LEGNLegend Biotech Corporation

$20.67

$16.6552 weeks$37.71

Price

$20.67-45%1Y

1M-12%1Y-45%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Top tier

9/10

Value97

Quality55

Momentum36

Growth85

Strongest Value, weakest Momentum · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

We are a global biopharmaceutical company engaged in the discovery, development, manufacturing and commercialization of novel cell therapies for oncology and other indications. Our team of approximately 2,900 employees in the United States, China and Europe, our differentiated technology, global development and manufacturing strategy and expertise provide us with the ability to generate, test and manufacture next-generation cell therapies targeting indications with high unmet needs.

In the company’s own words · 20-F filed Mar 10, 2026 · SEC EDGAR

P/E (TTM)-

Market Cap$5.19B

1Y Return-45%

5Y Return-52%

For the full year FY2025, revenue was $1.03B (+64% year on year) and net income −$297M.